Washington University School of Medicine in St Louis has been awarded a five-year $10.8 million grant to further its programmes in leukaemia and other blood cancers.  The grant, from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), renews funding for the Specialized Program of Research Excellence (SPORE) in leukaemia.   Siteman Cancer […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!